Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review by Fischer Walker, Christa L et al.
RESEARCH ARTICLE Open Access
Diarrhea incidence in low- and middle-income
countries in 1990 and 2010: a systematic review
Christa L Fischer Walker
1*, Jamie Perin
1, Martin J Aryee
2, Cynthia Boschi-Pinto
3 and Robert E Black
1
Abstract
Background: Diarrhea is recognized as a leading cause of morbidity and mortality among children under 5 years
of age in low- and middle-income countries yet updated estimates of diarrhea incidence by age for these
countries are greatly needed. We conducted a systematic literature review to identify cohort studies that sought to
quantify diarrhea incidence among any age group of children 0-59 mo of age.
Methods: We used the Expectation-Maximization algorithm as a part of a two-stage regression model to handle
diverse age data and overall incidence rate variation by study to generate country specific incidence rates for low-
and middle-income countries for 1990 and 2010. We then calculated regional incidence rates and uncertainty
ranges using the bootstrap method, and estimated the total number of episodes for children 0-59 mo of age in
1990 and 2010.
Results: We estimate that incidence has declined from 3.4 episodes/child year in 1990 to 2.9 episodes/child year in
2010. As was the case previously, incidence rates are highest among infants 6-11 mo of age; 4.5 episodes/child
year in 2010. Among these 139 countries there were nearly 1.9 billion episodes of childhood diarrhea in 1990 and
nearly 1.7 billion episodes in 2010.
Conclusions: Although our results indicate that diarrhea incidence rates may be declining slightly, the total burden
on the health of each child due to multiple episodes per year is tremendous and additional funds are needed to
improve both prevention and treatment practices in low- and middle-income countries.
Background
Diarrhea remains a leading cause of mortality among
children under 5 years of age around the world [1]. The
burden of Diarrheal disease disproportionately affects
young children in low- and middle-income countries
who have higher incidence rates due to inadequate
water and sanitation and nutritional risk factors, such as
suboptimal breastfeeding and zinc and vitamin A defi-
ciency [2-4]. Children living in impoverished areas also
have higher case-fatality rates compared to children liv-
ing in high-income countries due to lack of access to
quality health care and timely and effective treatment
with oral rehydration solution (ORS) and zinc [5].
There is currently no widely available source for diar-
rhea incidence estimates. While cross-sectional surveys
such as Demographic and Health Surveys routinely
gather 2-week point prevalence rates for low- and mid-
dle-income countries around the world, these data can-
not be used to generate incidence rates because they
can be highly affected by seasonal variation in incidence.
Age-specific incidence rates acquired from cohort stu-
dies including at least 1 year of surveillance are the best
source of data, but these are not available for every
country. Therefore, we rely on modeling to generate
estimates by country and region, and for the world.
Snyder and Merson first estimated diarrhea incidence
for young children to be 2.2 episodes/year in 1980 using
available data published between 1954 and 1979 [6].
Ten years later Bern et al. published an update of this
review using similar methodology, including more
recent studies, and estimated children to have 2.6 epi-
sodes of diarrhea/year [7]. In 2003, Kosek et al. provided
another updated estimate of diarrhea morbidity conclud-
ing that children have 3.2 episodes of diarrhea/year [8].
Given it has been nearly 10 years since the last pub-
lished estimate of diarrhea morbidity, there is a great
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any medium, provided the original work is properly cited.need for updated estimates of incidence rates for calcu-
lating burden of disease and for planning at the country
level. In addition, numerous studies have been published
since the last review; thus, we sought to include updated
data, as well as improve upon past search strategies to
expand the contributing of literature.
Methods
Systematic review and data abstraction
We conducted a systematic literature review to identify
community-based cohort studies of children 0-59 mo of
age with at least 12 mo of diarrhea surveillance. Diar-
rhea was defined as 3 or more loose or watery stools in
24 h. We searched PubMed, Embase, Global Health,
and the WHO Regional Databases and used all combi-
nations of the following search terms: diarrh(o)ea, child,
morbidity, incidence, surveillance, burden of disease, and
prevalence. We sought papers with diarrhea incidence
data. We included papers in English, French, Spanish,
and Italian published between 1980 and Aug 31, 2010 in
our search. We excluded papers with recall periods
beyond 2 weeks and those conducted in unrepresenta-
tive populations (i.e. low birth weight infants or children
with chronic disease). We sought unpublished datasets
by contacting authors known globally for their large
community-based study sites, but held them to the
same inclusion/exclusion standards. The initial search
was conducted in June 2008 and was updated on Sept
15, 2010. We first screened titles and abstracts, and
then full manuscripts for all potentially eligible papers
(Figure 1). Final papers were abstracted by two trained
data abstractors into a standardized abstraction
spreadsheet.
Data analysis
We used empirical data from the literature on diarrhea
incidence to estimate age-specific incidence rates for
139 low- and middle-income countries,
a based on each
country’s WHO region and under five mortality rate.
Reported incidence rates varied widely in the literature
and many studies presented truncated age cohorts (for
example, a study may include only children 0-23 mo of
age) or non-standard age groupings (for example, the
incidence for children 8-21 mo of age in lieu of 6-11
and 12-23 mo of age). Standard age categories include
0-5 mo, 6-11 mo, 12-23 mo, 24-35 mo, 36-47 mo, and
Figure 1 Flow chart diagram of the systematic review process.
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Page 2 of 748-59 mo. If all studies reported incidence rates using
standard age groups, a simple regression model could be
used to estimate the effect of covariates (e.g. WHO
region and under five mortality) on age-specific inci-
dence. However, because a range of non-standard age
groups are reported and age-group specific data is
sparse in many regions, we made the simplifying
assumption that the shape of the incidence rate age
curve is the same across all countries. (e.g. the ratio of
12-23 mo incidence is a fixed multiple of the 6-11 mo
incidence regardless of country). Country-specific char-
acteristics (i.e. WHO region and under five mortality)
shift the incidence curve up or down, but do not alter
the shape of the curve. The specific shape of this curve
is estimated by all studies which included 0-59 and at
least 1 age category; for this analysis this included 65 of
72 studies.
To convert non-standard age group reports into preset
age groups we modeled through a two-stage iterative
process using the Expectation-Maximization (EM) algo-
rithm. The EM algorithm can be applied to data sets
with missing or incomplete data [9-11]. The analysis is
separated into two distinct steps. We first used the cur-
rent estimate of the incidence rate age curve to convert
the observed age groups into the standard age groups.
For example, an incidence rate reported for the age
group 1-23 months would be converted into estimates
for 0-5, 6-11, and 12-23 mo. This step is similar to an
imputation where we obtain best guess estimates of the
incidence rates that would have been observed had the
standard age groups been reported. In the second step
we then fit a regression model to the standardized age
group incidence rates to estimate the parameters for
curve shape, WHO region and under five mortality rate.
The updated curve shape parameters are then used
again in the first step and the process iterates repeatedly
until the incidence estimates are stable.
We weighted country level incidences predicted by
this model by the population of children under the age
of five to calculate regional age-specific estimates. In
order to approximate uncertainty for regional rates, we
used the nonparametric bootstrap [12] to resample
study data by WHO region. We fit the model repeatedly
with resampled data and weighted averages taken from
the incidences predicted by country. We report the
2.5th and 97.5th percentiles from the resulting distribu-
tion of incidence for each region using a standard non-
parametric bootstrap estimator that has an approximate
0.95 probability of including the true regional incidence
represented by the study data [13]. We also used these
distributions of predicted incidences by region to deter-
mine if observed differences were spuriously detected
and within random prediction error, or whether the dif-
ference in incidence over time is statistically supported
by data. Because incidence is modeled using only WHO
region and under five mortality rates, the estimated
change in incidence over time is driven by changes in
under five mortality. Under 5 mortality steadily declined
from 1990 to 2010 in most countries so testing for a
decline in incidence is equivalent to testing that this
relationship is statistically significant.
We then calculated the total number of episodes of
diarrhea among the 139 low- and middle-income coun-
tries included in this analysis by multiplying our esti-
mated regional diarrhea incidence rates for all children
0-59 mo of age by the total population of children
under 5 years of age for both 1990 and 2010.
Results
Systematic literature review
We screened more than 19,000 possible titles to identify
72 studies that met all inclusion and exclusion criteria
(Figure 1). The studies were from 5 of the 6 WHO
regions (all except Europe) (Figure 2) and were pub-
lished between 1980 and 2010 representing data collec-
tion between 1976 and 2006. We abstracted age-specific
incidence rates for all age categories described in the
studies; this included 50 different age categories and 187
individual incidence rates from among these 72 studies
that were included in the age adjustment and modeling
methods. Study characteristics including site, study type,
urban or rural setting, year of data collection, sample
size, and incidence rate by age for the 72 included stu-
dies can be found in Additional file 1.
Diarrhea Incidence by age and region
Using the age-specific data we produced country-speci-
fics estimates for each age category (0-5 mo, 6-11 mo,
12-23 mo, and 24-59 mo) for 1990 and 2010 (Additional
file 2). The country level data were then aggregated up
to create regional estimates for 1990 and 2010 (Tables 1
and 2). For 1990 diarrhea incidence rates were highest
among children 6-11 mo of age (5.3 episodes/child year)
and lowest among children 24-59 mo of age (2.7 epi-
sodes/child year. Overall children experienced 3.4 epi-
sodes of diarrhea per year. Using 1990 population
estimates for children 0-59 mo of age we estimate that
there were nearly 1.9 billion episodes of diarrhea among
children living in the 139 countries included in these
analyses (Table 3). For 2010 diarrhea incidence rates
remained highest among infants 6-11 mo of age and
dropped from 5.3 to 4.5 episodes per year during this
20-year period. Again, children 24-59 mo of age had the
lowest estimated incidence rate at 2.3 episodes/child
year. Overall incidence rates declined from 1990 to 2010
(p < 0.05) in all regions with the greatest decline
observed in Africa (4.2 to 3.3 episodes/child year). In
2010, each child experienced an estimated 2.9 episodes
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children less than 5 years of age in low- and middle-
income countries.
Discussion
We estimated diarrhea incidence rates among children
under 5 years of age living in low- and middle-income
countries in 6 WHO regions and for the world for 1990
and 2010. We found that while diarrhea incidence has
declined from an estimated 3.4 episodes/child year in
1990 to 2.9 episodes/child year in 2010, the highest bur-
den of disease has remained consistent with respect to
age (i.e. with 6-11 mo olds having the highest inci-
dence). The decline we present here from 1990 and
2010 is strongly correlated with the overall decline in
under 5 mortality rates observed during this same per-
iod. With the model presented here we observe overlap-
ping uncertainty bounds for the point estimates, yet still
observe a statistically significant decline over time when
testing the statistical significance of the rate of decline
using the bootstrap model.
Our estimates are in line with previously published
estimates of 2.2 episodes/child year in 1980, [6] 2.6 epi-
sodes/child year in 1990, [7] and 3.2 episodes/child year
Figure 2 Location of studies reporting Diarrhea incidence outcomes for children and adults.
Table 1 Diarrhea incidence rates by WHO region for 1990
Age
Episodes of Diarrhea per child year (Uncertainty bounds)
Region 0-5 months 6-11 months 12-23 months 24-59 months 0-59 months
Africa 4.3 (2.9, 7.6) 6.5 (4.7, 11.6) 5.3 (3.6, 9.3) 3.4 (2.3, 6.0) 4.2 (3.0, 7.3)
Americas 4.6 (3.4, 5.8) 7.0 (5.3, 8.4) 5.7 (4.3, 6.6) 3.6 (2.6, 4.6) 4.5 (3.4, 5.3)
Eastern Mediterranean 3.6 (1.8, 5.9) 5.4 (3.0, 8.3) 4.4 (2.4, 6.6) 2.8 (1.6, 4.3) 3.5 (2.0, 5.2)
Europe 4.5 (3.3, 5.7) 6.9 (5.2, 8.2) 5.6 (4.3, 6.5) 3.6 (2.5, 4.5) 4.4 (3.4, 5.2)
South East Asian 3.1 (2.0, 4.6) 4.7 (3.3, 6.3) 3.8 (2.7, 5.0) 2.4 (1.8, 3.1) 3.0 (2.2, 3.8)
Western Pacific 2.6 (1.5, 3.3) 4.0 (2.2, 4.8) 3.2 (1.8, 3.7) 2.0 (1.2, 2.4) 2.5 (1.4, 2.8)
Global 3.4 (2.6, 4.7) 5.3 (4.4, 6.4) 4.3 (3.5, 5.1) 2.7 (2.2, 3.3) 3.4 (2.9, 3.9)
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updated search strategy and difference in age-adjust-
ment as part of the analytic methods. We conducted an
extensive literature review and included languages and
databases that may have been overlooked in the past. In
addition, the passage of time afforded us the opportunity
to include more studies that were not included in the
past. With these changes the total number of included
studies went from 27 in the most recent 2003 estimate
[8] to 72 in our current review and analysis. However,
despite this increase in total studies identified, very few
(n = 14) of theses are from 2000 or beyond thus the
need for more recent data to better estimate current
incidence rates remains an issue.
We have also employed a number of analytic changes
that we believe strengthen the estimation process and
the certainty of our final estimates. We used an analytic
method not previously used in diarrhea incidence calcu-
lations, i.e. the Expectation Maximization algorithm, to
incorporate incidence rates reported by authors for non-
standard age categories (i.e. any age category other than
0-5, 6-11, 12-23, 24-35, 36-48, and 0-59 mo). In the
past, age-specific data was only used if it fit into these
(or fewer) standard age categories. Unfortunately this
limited the inclusion of much of the age-specific data.
We found data in 50 different unique age categories.
B e c a u s ei n c i d e n c er a t e sv a r yb ya g e ,t h ei n c l u s i o no fa s
much age-specific data as possible is critical to the
improvement of the estimation process. We also used
country level covariates as part of the regression model.
These country-level data improve upon taking simple
weighted means or median incidence rates by allowing
for the influence to vary based on the location of the
input studies and national level data.
We recognize our study has several limitations. While
the 72 studies identified and included in this analysis
represent a substantial improvement upon past esti-
mates, this number of studies is still low considering an
inclusion period for studies of more than 30 years. In
addition, while we are estimating using all data for two
time periods it should be pointed out that only 14 of
these studies contained data from the year 2000 and
beyond. Thus, estimates for the recent past (i.e. 2010)
are predominantly based on older data relying on
changes in model level covariates to adjust for diarrhea
incidence changes over time rather than empirical data.
This lack of data highlights the paucity of routine cohort
studies conducted within the last decade raises great
concern given that the estimates presented here con-
tinue to suggest that diarrhea is an enormous health
burden for children in low- and middle-income
countries.
We modeled diarrhea incidence for each country
using published country level and under 5 mortality
Table 2 Diarrhea incidence rates by WHO region for 2010
Age
Episodes of Diarrhea per child year (Uncertainty bounds)
Region 0-5 months 6-11 months 12-23 months 24-59 months 0-59 months
Africa 3.4 (2.1, 5.6) 5.1 (3.4, 8.1) 4.2 (2.7, 6.4) 2.7 (1.7, 4.2) 3.3 (2.2, 5.1)
Americas 4.1 (2.9, 5.2) 6.2 (4.7, 7.5) 5.0 (3.9, 5.8) 3.2 (2.3, 4.0) 4.0 (3.1, 4.7)
Eastern Mediterranean 3.1 (1.5, 5.2) 4.7 (2.4, 7.0) 3.8 (1.9, 5.4) 2.4 (1.3, 3.6) 3.0 (1.6, 4.4)
Europe 4.1 (3.0, 5.3) 6.3 (4.8, 7.6) 5.1 (3.9, 5.9) 3.2 (2.3, 4.1) 4.0 (3.1, 4.7)
South East Asian 2.4 (1.4, 4.0) 3.7 (2.2, 5.6) 3.0 (1.8, 4.3) 1.9 (1.2, 2.6) 2.4 (1.5, 3.3)
Western Pacific 2.3 (1.3, 3.1) 3.5 (2.0, 4.4) 2.9 (1.6, 3.3) 1.8 (1.1, 2.2) 2.3 (1.3, 2.6)
Global 2.9 (2.1, 4.3) 4.5 (3.4, 5.7) 3.6 (2.8, 4.4) 2.3 (1.8, 2.8) 2.9 (2.3, 3.4)
Table 3 Total Diarrhea episodes among children under 5 years of age living in low- and middle-income countries for
1990 and 2010
1990 2010
WHO Region (number of low-/middle












Africa (45) 4.2 92,112,710 386,873,382 3.3 135,986,600 448,755,780
Americas (29) 4.5 55,097,140 247,937,130 4.0 55,069,550 220,278,200
Eastern Mediterranean (15) 3.5 60,682,760 212,389,660 3.0 66,458,970 199,376,910
Europe (23) 4.4 37,236,710 163,841,524 4.0 27,836,060 111,344,240
South East Asian (11) 3.0 175,764,800 527,294,400 2.4 182,015,100 436,836,240
Western Pacific (16) 2.5 143,774,300 359,435,750 2.3 110,854,400 254,965,120
Total Diarrhea Episodes 1,897,771,846 1,671,556,490
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water and sanitation, breastfeeding practices, rotavirus
vaccine coverage, etc., i.e. indicators that are widely
known to directly influence diarrhea morbidity rates.
We attempted to include these indicators and sought
study level data for each of these during the initial
abstraction process; however, unfortunately most pub-
lished papers did not include study level data on these
covariates. In our previous models, where study level
data were missing, we used country level indicators
from DHS surveys, but during the modeling process
these covariates did not prove to be predictive of diar-
rhea incidence and fell out of all early versions of the
r e g r e s s i o nm o d e l s .T h i si sn o ts u r p r i s i n gb e c a u s es m a l l
study sites can often be drastically different from the
country where they are conducted with regard to com-
mon socioeconomic and child health indicators collected
in large cross sectional surveys. In addition, some inter-
ventions such as vitamin A supplementation, are better
linked to reductions in diarrhea mortality than to reduc-
tion in diarrhea incidence. In our final model we
included only under 5 mortality rates. While we recog-
nize that this indicator could also be improved with
l o c a l ,s i t e - s p e c i f i cd a t at ob e t t e rr e l a t et h es t u d yl e v e l
incidence, it proved to be more statistically sound than
indicators such as access to water and sanitation, that
were tested in early versions. Gross National Income
(GNI) also fell out of the model due to colinearity with
reduction in under 5 mortality rates over time.
Introducing new analytic methods has the potential
for new sources of error. We chose to use the ratio of
age specific rates as a feature of the incidence data.
These ratios can be observed in the raw study data
where at least two ages are reported exactly as we have
specified, i.e., as 0-5 mo, 6-11 mo, 12-23 mo, or 24-59
mo. Thirteen studies reported incidence rates for 0-5
mo and 6-11 mo; the average ratio of incidence (6-11
mo compared to 0-5 mo) in the study data was 1.392,
while our model predicts a ratio of 1.389. For the age
groups 6-11 mo and 12-23 mo (n = 10 studies), the
average ratio of incidence among study data for 12-23
mo compared to that for 6-11 mo was 0.780, while our
model predicts a ratio of 0.779. There are no studies
where 24-59 mo is reported along with another standard
age group.
Diarrhea incidence remains a tremendous burden on
children in low- and middle-income countries. Diarrhea
has been shown to have a lasting influence on nutri-
tional status in that an increase in diarrhea prevalence
has been linked to an increased risk of stunting [14] and
diarrhea has been shown to be a risk factor for pneumo-
nia [15]. As diarrhea mortality rates continue to decline
it becomes increasingly important to emphasize the role
of frequent diarrhea episodes experienced by the
surviving children. While both case fatality rates and
i n c i d e n c er a t e sm a yb ed e c l i n i n g ,b o t hd e c l i n e sa r e
occurring too slowly given the breadth of available ther-
apeutic and preventive interventions. The coverage of
therapeutic interventions, namely ORS and zinc remains
poor throughout developing countries. Although water
and sanitation services have improved since 1990, other
possible modes of enteric pathogen transmission, such
as contaminated food or poor personal hygiene, may not
have. Exclusive breastfeeding practices for the first 6 mo
of life and continued breastfeeding until 24 mo of age
continue to need improvement in nearly all low- and
middle-income countries. Because diarrhea has several
transmission routes, it can be hypothesized that simply
removing one such route does not eliminate the risk of
diarrhea [16]. It has been observed that the protective
effect of improved water quality is greater among com-
munities with improved sanitation conditions compared
to higher contaminated areas [17]. Thus, for substantial
changes in diarrhea incidence rates due to the most
common pathogens, multiple transmission routes need
to be eliminated simultaneously at the household and
community level.
Conclusions
Children in low- and middle-income countries remain at
risk for frequent diarrhea episodes and thus for second-
ary infections and the long-term sequel of delayed, or
never attained growth. It is becoming increasingly
important to focus on improved delivery strategies to
enhance access to diarrhea prevention and treatment
programs as well as the development of new technolo-
gies including vaccines which may help future
generations.
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Endnote
a A f r i c a :A l g e r i a ,A n g o l o a ,B e n i n ,B o t s w a n a ,B u r k i n a
Faso, Burundi, Cote d’Ivoire, Cameroon, Cape Verde,
Centra African Republic, Chad, Comoros, Congo,
Democratic Republic of Congo, Eritrea, Ethiopia, Gabon,
Gambia, Ghana, Guinea-Bissau, Guinea, Kenya, Lesotho,
Liberia, Madagascar, Malawi, Mali, Mauritania, Mauri-
tius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao
Tome and Principe, Senegal, Seychelles, Sierra Leone,
South Africa, Swaziland, Togo, Uganda, United Republic
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Page 6 of 7of Tanzania, Zambia, Zimbabwe. Americas: Antigua and
Barbuda, Argentina, Belize, Bolivia, Brazil, Chile, Colom-
bia, Costa Rica, Cuba, Dominica, Dominican Republic,
E c u a d o r ,E lS a l v a d o r ,G r e n a d a ,B u a t e m a l a ,G u y a n a ,
Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama,
Peru, Saint Lucia, Saint Vincent, Suriname, Uruguay,
Venezuala. Eastern Mediterrean: Afghanistan, Djibouti,
Egypt, Iran, Iraq, Jordan, Lebaon, Libyan Arab Jamahir-
iya, Moocco, Pakistan, Somalia, Sudan, Syrian Arab
Republic, Tunisia, Yemen. Europe: Albania, Armenia,
Azerbaijan, Belarus, Bosnia and Herzegovinia, Bulgaria,
Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Mol-
dova, Montenegro, Occupied Palestian Territory, Roma-
nia, Russian Federation, Serbia, Tajikistan, TFYR
Macedonia, Turkey, Turkmenistan, Ukraine, Uzbekistan.
South East Asia: Bangaldesh, Bhutan, Dem. People’s
Republic of Korea, India, Indonesia, Maldives, Myan-
man, Nepal, Sri Lanka, Thailand, Timore Leste. Western
Pacific: Cambodia, China, Fiji, Kiribati, Lao People’s
Democratic Republic, Malaysia, Marshall Islands, Mon-
golia, Papua New Guinea, Philippines, Samoa, Solomon
Islands, Taiwan, Tonga, Vanuatu, Viet Nam.
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